Pfizer Inc. (PFE) Q2 2011 Earnings Results

Pfizer Beats on EPS, Stock Down 4.58%

Pfizer's earnings report showed a slight beat on EPS, indicating some operational strength. However, the stock dropped 4.58% in reaction, likely due to the lack of revenue figures and no guidance update, which left investors uncertain about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.60	N/A	+2.21%

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to long-term strategies despite current market challenges.

We are pleased with our EPS performance this quarter.

While we face challenges, we remain committed to our strategic goals.

Pfizer Beats on EPS, Stock Down 4.58%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 4.58%

Key numbers

Management commentary